These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 25171027

  • 1. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
    Yilmaz Y, Eren F.
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E, Lee TP.
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [Abstract] [Full Text] [Related]

  • 3. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.
    Gunn NT, Shiffman ML.
    Clin Liver Dis; 2018 Feb; 22(1):109-119. PubMed ID: 29128050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
    Castera L.
    Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
    [Abstract] [Full Text] [Related]

  • 9. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.
    Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V.
    Am J Gastroenterol; 2013 Sep; 108(9):1526-31. PubMed ID: 23752877
    [Abstract] [Full Text] [Related]

  • 10. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers.
    Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Mori K, Tanaka S, Yamada M, Akita M, Mizutani K, Fujii H, Yamamoto A, Takamatsu S, Yoshida Y, Itoh Y, Kawada N, Chayama K, Saibara T, Takehara T, Miyoshi E.
    Hepatology; 2015 Nov; 62(5):1433-43. PubMed ID: 26199205
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
    Gao F, Huang JF, Zheng KI, Pan XY, Ma HL, Liu WY, Byrne CD, Targher G, Li YY, Chen YP, Chan WK, Zheng MH.
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1804-1812. PubMed ID: 32246876
    [Abstract] [Full Text] [Related]

  • 12. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Sumida Y, Nakajima A, Itoh Y.
    World J Gastroenterol; 2014 Jan 14; 20(2):475-85. PubMed ID: 24574716
    [Abstract] [Full Text] [Related]

  • 13. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Pimentel CF, Jiang ZG, Otsubo T, Feldbrügge L, Challies TL, Nasser I, Robson S, Afdhal N, Lai M.
    Dig Dis Sci; 2016 Mar 14; 61(3):905-12. PubMed ID: 26462489
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P, Sayiner M, Fazel Y, Koenig A, Henry L, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2016 Mar 14; 10(1):63-71. PubMed ID: 26469309
    [Abstract] [Full Text] [Related]

  • 18. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
    Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG.
    World J Gastroenterol; 2007 Feb 14; 13(6):837-44. PubMed ID: 17352011
    [Abstract] [Full Text] [Related]

  • 19. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
    Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K.
    J Clin Gastroenterol; 2010 Jul 14; 44(6):440-7. PubMed ID: 20104187
    [Abstract] [Full Text] [Related]

  • 20. The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.
    Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ.
    J Gastroenterol Hepatol; 2016 May 14; 31(5):995-1000. PubMed ID: 26589761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.